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Abstract
Despite highly active antiretroviral therapy (HAART), AIDS related lymphoma (ARL) occurs at a significantly higher rate in
patients infected with the Human Immunodeficiency Virus (HIV) than in the general population. HIV-infected macrophages
are a known viral reservoir and have been shown to have lymphomagenic potential in SCID mice; therefore, there is an
interest in determining if a viral component to lymphomagenesis also exists. We sequenced HIV-1 envelope gp120 clones
obtained post mortem from several tumor and non-tumor tissues of two patients who died with AIDS-related Non-
Hodgkin’s lymphoma (ARL-NH). Similar results were found in both patients: 1) high-resolution phylogenetic analysis showed
a significant degree of compartmentalization between lymphoma and non-lymphoma viral sub-populations while viral sub-
populations from lymph nodes appeared to be intermixed within sequences from tumor and non-tumor tissues, 2) a 100-
fold increase in the effective HIV population size in tumor versus non-tumor tissues was associated with the emergence of
lymphadenopathy and aggressive metastatic ARL, and 3) HIV gene flow among lymph nodes, normal and metastatic tissues
was non-random. The different population dynamics between the viruses found in tumors versus the non-tumor associated
viruses suggest that there is a significant relationship between HIV evolution and lymphoma pathogenesis. Moreover, the
study indicates that HIV could be used as an effective marker to study the origin and dissemination of lymphomas in vivo.
Citation: Salemi M, Lamers SL, Huysentruyt LC, Galligan D, Gray RR, et al. (2009) Distinct Patterns of HIV-1 Evolution within Metastatic Tissues in Patients with
Non-Hodgkins Lymphoma. PLoS ONE 4(12): e8153. doi:10.1371/journal.pone.0008153
Editor: Darren P. Martin, Institute of Infectious Disease and Molecular Medicine, South Africa
Received September 9, 2009; Accepted November 6, 2009; Published December 3, 2009
Copyright:  2009 Salemi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: M.S. research is supported in part by PHS R01 awards NS063897 and AI065265, the Laura McClamma Fellowship, the Center for Research in Pediatric
Immune Deficiency and Stephany W. Holloway University Chair for AIDS Research. R.R.G. is supported by a T32 award CA09126. S.L.L., L.C.H, D.G, A.M. and M.S.M
are supported from NIH grants U01 CA096230-06 and U01 CA066529-14. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: salemi@pathology.ufl.edu (MS); mmcgrath@php.ucsf.edu (MSM)
Introduction
AIDS related lymphoma (ARL) is a disease that occurs in 3–4%
of patients infected with the human immunodeficiency virus (HIV)
despite the initiation of highly active antiretroviral therapy
(HAART) [1]. Since the introduction of HAART, the overall
incidence of ARL has been reduced approximately 50%; however,
it still occurs at a rate much higher than in non-HIV infected
individuals, suggesting a viral component is involved in the
development of ARL [1]. The primary difference between
lymphoma in non-HIV infected individuals and ARL is that
ARLs are uniformly high grade and widely metastatic, with death
occurring in as little as two weeks after diagnosis [2]. HIV-related
lymphomas are predominately of B-cell origin and often involve
extranodal sites, especially the liver and GI tract [3], with about
80% of ARLs arising in the periphery while the remaining occur in
the central nervous system (CNS) [4].
It has been proposed that the contribution of HIV to lymphoma
pathogenesis may be indirect, related to the duration of
immunosuppression, and/or the increased risk for opportunistic
infections with oncogenic herpes viruses such as Epstein Barr
Virus (EBV) and Human Herpes Virus 8 (HHV-8) [5]. However,
several studies show that the expansion of a clonal macrophage
population also plays a central initiating role in the early stage of
lymphoma development [6]. In non-AIDS settings, patients with
follicular lymphoma containing high levels of tumor-associated
macrophages (TAM) progress more rapidly than patients with
fewer TAM [7,8,9,10].
Zenger et al. [11] isolated TAM from two patients with ARL
and implanted them in SCID mice. Interestingly, most of the mice
implanted with the human TAM developed aggressive murine
lymphomas, which contained the human macrophages within the
tumor stroma. PCR analysis confirmed the presence of HIV
within the implanted macrophages and revealed that the SCID
mouse lymphomas were of murine origin. Additionally, T cells
isolated from the same patients with ARL and control macro-
phages isolated from healthy donors did not induce tumors in the
SCID mice, indicating that the HIV positive TAM from the ARLs
were responsible for the murine tumor development. Because HIV
positive TAM typically express IL-10 and IL-6, cytokines not
generally expressed by other forms of HIV infected macrophages
(i.e. macrophages in HIV-associated dementia), the finding
suggests that HIV indirectly contributes to lymphoma pathogen-
esis through the creation of tumorigenic microenvironments. In
fact, epidemiological studies have shown that increased antigen
presentation and macrophage inflammation is significantly
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of an anti-inflammatory environment [12].
Molecular studies have identified a subset of large cell
lymphomas with prominent fes-expressing macrophage popula-
tions. Fes is a tyrosine protein kinase associated with malignant
transformation in animal models, and with intracellular signaling
in macrophages initiated by macrophage colony-stimulating
factor, GM-CSF and IL-3 [13]. Ex vivo studies demonstrated that
TAMs from a subset of ARL patients contained monoclonally
integrated HIV, upstream to the c-fes oncogene, that was
associated with polyclonal B-cell lymphoma [14]. In general, the
sequential pathogenesis model of ARL suggests the following steps
toward disease development: 1) HIV integration near a gene that
promotes cellular proliferation; 2) macrophage proliferation; 3)
production of lymphostimulatory products in oligoclonal macro-
phages leading to polyclonal proliferation of B-cells and mono-
clonal outgrowths; 4) tumorigenesis [3].
Despite an abundance of evidence that implicates HIV-infected
macrophages in lymphomagenesis, no studies to date have
investigated the evolutionary dynamics of HIV quasispecies
infecting tumor and non-tumor tissues from patients with ARL.
In the present work, we use high-resolution phylodynamic analysis
[15,16] to track the evolution of HIV-infected tumor and non-
tumor tissues harvested at autopsy from two patients who died of
lymphoma. The results show that the virus segregates in tumor-
associated macrophages and exhibits a distinct population dynamic
signature that may be linked to disease onset and progression.
Results
Multisite autopsy specimens from both patients, AM and IV,
were stained with H&E to determine if tumor was present within
the collected tissues (Supplemental Table S1). For AM, tumor was
identified in the left axillary lymph node, spleen, liver, gastric wall,
and diaphragm. For IV, tumor was identified in the right and left
axillary lymph nodes, lung, omental, and periaortic lymph node,
as well as kidney, spleen, diaphragm, and gastric wall. Tissue
sections were also double-stained for the macrophage marker
CD68 and the HIV gag antigen p24 as described in the Materials
and Methods. Our results show that a subset of the TAMs
identified with CD68 staining was also positive for HIV p24
(Figure 1). Tissues that were identified as non-involved did not
stain positive for p24 and had low levels of CD68 staining (not
shown). These data suggest that the macrophages identified with
CD68 staining also stain positive for p24 and that in these two
patients, HIV-infected macrophages are infiltrating tumor tissues,
similar to what we have previously described [11].
Phylogenetic Analysis of HIV-1 in Post-Mortem Tumor and
Non-Tumor Tissues
Maximum clade credibility trees, obtained from the posterior
distribution of trees, for both subjects are shown in Figure 2. ML
and NJ trees, as well as Bayesian trees obtained assuming the non-
clock model implemented in MrBayes, gave the same topology
(data not shown). HIV genealogies for subjects AM and IV
displayed a striking separation of the tumor-associated virus from
virus isolated from normal tissues. In subject AM, viral strains
from tumor tissues clustered in three distinct and well supported
(p.0.95) monophyletic clades. The major tumor clade also
contained a sub-clade that joined viral sequences from normal
kidney tissue( Figure 2A). Viral sequences from non-tumor tissues
formed a well-supported monophyletic clade distinct from the
major tumor-associated clades. A few viral strains from spleen
tumor also appeared to intermix within the non-tumor tissue
clade. Viruses isolated from lymph nodes were interspersed within
the largest tumor clade as well as the largest non-tumor tissue
clade. Interestingly, viral strains from the left lymph node (where
follicular hyperplasia was first diagnosed two months prior to the
patient’s death) clustered exclusively with the tumor tissue clade,
while viruses from the right lymph node clustered exclusively
within the non-tumor clade.
HIV sequences from subject IV were obtained from a different
set of lymphoid and non-lymphoid tissues than subject AM, but
the viral genealogy displayed a remarkably similar compartmen-
talization between tumor and non-tumor derived strains. The tree
showed a monophyletic clade that contained the majority of viral
strains from tumor tissues and a distinct lineage containing
sequences from normal stomach tissue, all highly supported
(p.0.8). Sequences from lymph nodes were interspersed in the
tumor clade and viruses from the right and periaortic lymph nodes
branched near the non-tumor clade. Sequences from the gastric
wall tumor tissue contained two evolutionary distinct and well-
supported clades.
In both subjects, prediction of co-receptor usage was consistent
with CD68/p24 staining of tumor tissues. All strains belonging to
Figure 1. Histopathology of p24 positive macrophages. Tissues from AM and IV were co-stained to identify infiltrating macrophages (CD68,
red) and cells productively infected with HIV (p24, brown). Representative tissues of the left axillary lymph node from patient AM (A) and the spleen
from patient IV (B) are shown. Examples of double-stained p24 positive macrophages are highlighted by the black arrows. Images are shown at 400X.
The distribution and staining pattern similar in all tumor-containing tissues analyzed (not shown).
doi:10.1371/journal.pone.0008153.g001
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usually associated to macrophage-tropic strains [17], while higher
charges (.+4), generally associated with T-cell tropism, were
typical of sequences within the major non-tumor clades (Figure 2).
The hypothesis of compartmentalization of the viral quasispe-
cies between tumor and non-tumor tissues was specifically tested
using the phylogeny-based test developed by Slatkin and
Maddison [18]. Genealogies from both subjects showed a
significant lower number of intermixing between HIV-1 sequences
from tumor and non-tumor tissues than expected under panmixia
(p,0.0001), thus providing strong evidence of viral compartmen-
talization in tissues with different histopathology. Overall, the
results clearly demonstrated that the HIV strains within tumor
associated macrophages in both subjects belonged to a unique
viral population that was phylogenetically distinct from the strains
infecting macrophages and T cells in non-tumor tissues.
Viral Population Dynamics in Tumor and Non-Tumor
Tissues
In order to investigate HIV demographic history in tumor and
non-tumor tissues of both subjects, we analyzed separately four
sub-datasets, each one including only viral strains clustering in the
major tumor or non-tumor clade of each genealogy (clades
highlighted by squares in Figure 2). Several coalescent models of
viral effective population size (Ne) change over time were tested
using a Bayesian framework. Bayes Factors (BF) were employed to
compare a null model of constant population with parametric
(exponential) and non-parametric Bayesian skyline plot (BSP)
models of growth. For both subjects, no or weak evidence was
found against the null model when viral strains from normal tissues
were considered, although the BSP model was slightly above the
cutoff for patient AM (Supplemental Table S2). On the other
hand, in both subjects the exponential and BSP models fitted the
data significantly better than the constant one for the viral sub-
population infecting tumor tissues, with the BSP model always
displaying the highest marginal likelihood (data not shown). Under
the exponential model, Bayesian estimates of HIV effective
population size growth rate, as well as 95% high posterior density
(95%HPD) intervals of the estimates, were also remarkably similar
for both subjects (AM: median 10.2, 95%HPD 6.8–14.4; IV:
median 10.7, 95%HPD 6.9–14.9).
A low and constant Ne, estimated between 1–10 effectively
infectious genomes, characterized the HIV population dynamic in
non-tumor tissues (Figure 3 top panels) during the last year of the
patients’ life. However, in the tumor tissues, Ne increased more
than 100-fold during the last three months of the infection
coincident to the clinical onset of lymphoma (Figure 3 bottom
panels). The 95%HPD intervals of Ne for the beginning and
ending estimates did not overlap, consistent with the significant BF
for the demographic models assuming population growth in these
clades.
Molecular Clock Analysis
One hypothesis that could explain the increase in viral Ne within
tumor clades is a higher viral evolutionary rate leading to
increased diversity and resulting, in turn, into higher estimates of
effective population size over time. To address this hypothesis,
HIV-1 rate of evolution was investigated by enforcing a local
molecular clock on the trees in Figures 2A and 2B for viruses
derived from normal and tumor tissues, respectively, and a
baseline clock for the remaining part of the tree. The local clock
model was then compared with both a strict clock (one
evolutionary rate for the whole tree) and a non-clock model. As
expected, the non-clock model always fitted the data significantly
better than the strict or the local one (Supplemental Table S3).
However, the comparison between the strict and local molecular
clocks showed that the hypothesis of two different evolutionary
Figure 2. Phylogenetic analysis HIV-1 gp120 sequences from different tissues. Bayesian maximum clade credibility trees assuming a
relaxed molecular clock and constant population size coalescent prior generated from the posterior distribution of trees less a 50% burn-in. Branch
lengths are shown according to the scale bar at the bottom of each panel, in relative units of time (nucleotide substitutions per site). Posterior
probabilities for major nodes are indicated. Internal branches are colored according to the maximum parsimony reconstruction of the ancestral tissue
of origin: red=tumor; yellow or green=lymph node; blue=normal tissue. Posterior probability values.80% are shown along the branches. The
tissues of origin found within major clades are listed to the right with LN indicating lymph nodes. Number of sequences and V3 loop net charge
within the clade for each tissue are given in parentheses. A. Subject AM. Yellow and green lineages represent viral strains from right and left axillary
lymph nodes, respectively. B. Subject IV.
doi:10.1371/journal.pone.0008153.g002
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respectively, did not fit the data significantly better than the strict
clock (p.0.05). Therefore, the exponential increase of Ne over
time in tumor tissues was apparently not related to an increased
evolutionary rate of the virus in the infiltrating macrophages.
To investigate further whether the molecular clock was different
for synonymous or non-synonymous substitutions, we performed
the molecular-clock analysis using only 1st+2
nd nonsynonymous
codon positions or only synonymous 3
rd codon positions (see
Methods). In both cases, the strict clock could not be rejected
when compared to the local clock model. Moreover, when
synonymous 3
rd codon positions were analyzed, the strict-clock
model did not fit the data significantly worse than the non-clock
model (p.0.05). Since the synonymous substitution rate is
proportional to the replication rate of the virus [19], the result
strongly suggested that in both subjects HIV-1 replicated at a
similar rate in tumor and non-tumor tissues.
Viral Gene Flow among Post-Mortem Tissues
The HIV-1 genealogies from both subjects showed a high
degree of compartmentalization between viral strains from tumor
and non-tumor tissues with strains from lymph nodes intermixing
between the two (Figure 2). Therefore, we decided to analyze in
more detail HIV-1 metapopulation structure by quantifying the
relative amount of viral gene flow between tissue pairs. The
average number of migration events (viral gene flow) to/from
tissues characterized by different histopathology was inferred with
a modified version of the Slatkin and Maddison test [16,18] from
the distribution (minus the burnin) of the HIV-1 genealogies
obtained by Bayesian inference. The number of migrations was
normalized to calculate the percentage of viral genomes flowing
between tissues (Figure 4). For both subjects, the majority of gene
flow occurred between lymph nodes and the tumor tissues (AM:
61.6%; IV: 92.9%). In subject AM, more viruses were exchanged
from the tumor to the lymph nodes (46.9%) than in the opposite
direction. In subject IV, the majority of the virus flowed from the
lymph nodes to the tumors (78.6%). In both subjects the tumor
tissue and the lymph nodes contributed virus to the normal tissue
at less than 25% of the total gene flow, gene flow from lymph
nodes to normal tissues was generally low (15.4% and 7.1% in AM
and IV, respectively), and no flow was observed from normal to
tumor tissues. Gene flow counts were all statistically significant
when compared with a panmictic model of random flow among
tissues (p,0.001). Overall, these patterns echoed the topology of
Figure 3. HIV-1 population dynamics in tumor and non-tumor tissues. Bayesian estimates of HIV-1 effective population size (number of
infectious genomes effectively contributing to the next generation, y-axis) over time (x-axis) were inferred using the models that fitted best for each
data set according to the Bayes Factors test (see Supplemental Table S2). The black line represents the median estimate of the effective population
size with the shaded area showing the 95% high posterior density intervals of the estimates. Top panels. Constant population size over time of HIV-
1 in normal tissues from patient AM (left panel) and IV (right panel). Bottom panels. Non-parametric estimates (Bayesian skyline plots) of effective
population size change over time for subject AM (left panel) and IV (right panel).
doi:10.1371/journal.pone.0008153.g003
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tumor tissues appeared highly compartmentalized with viral
strains from lymph nodes interspersed within different clades.
Discussion
The present study is the first to investigate HIV-1 evolutionary
patterns among tissues from lymphoma patients and to demon-
strate the existence of a distinct viral sub-population at least in part
associated with TAMs. Although further work will be required to
test the actual lymphomagenic potential of HIV lymphoma-
associated quasispecies, our findings have important implications
towards a thorough understanding of the nature of tumorigenesis
and suggest that HIV-1 DNA could provide a molecular marker
capable of tracking the spread of TAMs and thus tumor in vivo.
These data may have important implications for studying the role
of TAMs in the pathogenesis of cancer metastasis and as targets for
macrophage-specific therapeutic development.
The two ARL patients examined died within 2 to 4 weeks of
their diagnosis and phylodynamic analysis of HIV sequences from
post mortem tissues revealed several interesting aspects of viral
evolution: 1) both patients displayed remarkably similar patterns
suggesting the existence of tumor and non-tumor-specific viral
sub-populations, characterized by different growth rates; 2) the
results consistently showed that while HIV-1 strains were highly
compartmentalized between tumor and non-tumor tissues, strains
from lymph nodes were interspersed within the two groups; 3) the
presence of two different subpopulations of viruses in the patients
with lymphoma is not the result of drug selection since both
patients were HAART-naı ¨ve, and 4) HIV gene flow among
lymphoid and non-lymphoid tissues with different histopathology
was non-random. In particular, subject AM showed viral
sequences from left and right axillary lymph nodes compartmen-
talizing, respectively, with tumor and non-tumor tissues.
It is important to notice that although compartmentalization tests
clearlyshowedthatthe HIV-1subpopulationinfectingtumortissues
significantly differed from the one infecting non-tumor tissues, some
intermixing canstill be observed.The resultis not unexpected. First,
occasional exchange of virus (gene-flow) between contiguous tumor
and non-tumor cells is possible, as shown by gene-flow analysis
(Figure 4). Second, mixed tissue viral branches that occur between
the non-tumor and tumor clades may represent a biologically
ancestralform of the tumor virus.For example,patient IV showed a
population of lymph node, spleen and gastric wall sequences
branching out of the tumor clade that likely represented an older
population of sequences. Due to the high viral turnover in lymph
nodes, a mixture of viral populations from these tissues is expected.
In only one case do we see complete tissue compartmentalization,
and this is with Patient IV, stomach, non-tumor sequences. Van
Marle et al. showed that HIV sequences derived from the gut-
associated lymphoid tissues are frequently compartmentalized from
PBMC, and even from regions within the gut (stomach, esophagus,
duodenum, colon)[20]. In this sense, it is not surprising that normal
stomach is compartmentalized from the other tissues in the study,
yet it is interesting that nearly half of the tissues from a gastric wall
tumor were found within the tumor clade. If gut compartmental-
ization is common, then the only explanation for sequences in
tumor clade to be found in the gastric wall is due to the migration
and establishment of a metastaticmacrophage-harboring virus from
a site of tumorigenesis.
The finding of strongly compartmentalized populations of
sequences isolated from different tissues, especially tumor-
associated viruses within HAART-naı ¨ve ARL patients, suggests
two potential biological mechanisms: 1) the virus found in ARL is
migrating within metastatic macrophages and/or 2) lymphoma-
associated strains of HIV exist. This finding is significant because
the identification and characterization of lymphoma-specific viral
strains may shed further light into the study of lymphomagenic
processes. In particular, such viruses may contain specific protein
structures or amino acid substitutions, or may induce expression
patterns in macrophages that are associated with lymphoma onset
and progression.
One characteristic of end-stage AIDS is the presence of p24
expressing macrophages along with T cell depletion [8,9]. A recent
AIDS autopsy study showed that lymph nodes, spleen and brain
contained p24 expressing macrophages[21]. Additionally, previous
studies of ARL tissues demonstrated that p24 staining within
tumor tissues was predominantly localized to macrophages
interspersed in a background of p24-negative lymphocytes.
Laser-capture microdissection studies of these tissues localized
Figure 4. Viral gene flow analysis among different. Light blue arrows represent HIV-1 gene flow from/to normal tissues, tumor tissues and
lymph nodes. Viral gene flow among different tissues was inferred with a modified version of the Slatkin and Maddison method
13,28 from the HIV-1
genealogies including strains from different tissues. Numbers on the arrows represent percentage of observed migration in the genealogies. Left
panel. Subject AM. Right panel. Subject IV.
doi:10.1371/journal.pone.0008153.g004
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patients AM and IV pointed out that a subset of TAMs identified
with CD68 staining were also positive for HIV p24, implying that
at least some of the HIV sequences generated for this study were
derived from tumor associated tissue macrophages. Such conclu-
sion was strengthened as well by the predicted co-receptor usage
for the strains amplified from tumor tissues; however, the
possibility of harvesting lymphocytes from the tissues collected
exists. In one case, viruses from tumor tissues did not map within
the tumor clade (5 spleen tumor sequences in patient AM) and
contained highly charged V3 loop sequences. It is possible that
these represented viruses infecting lymphocytes present in the
sample.
Overall, these findings seem to indicate that during lymphoma
metastasis, the lymph nodes acted as the conduit of metastatic cells
migrating to distinct sites in the body and that the lymph nodes
exchanged virus with both non-tumor and tumor associated
TAMs. It has been recently proposed that metastasis is initiated by
hematopoietic progenitor cells (HPCs) and macrophages that co-
migrate to future metastatic sites establish a favorable microen-
vironment for the seeding of tumor cells [23,24,25]. These HPCs
and macrophages mobilize in response to growth factors produced
by the primary tumor, such as vascular endothelial growth factor
A (VEGFA), placental growth factor (PlGF) and transforming
growth factor-beta (TGFb), where they establish a pre-metastatic
niche. Our data suggest the possibility that a lymphoma specific
sub-population specifically infecting TAMs may promote lympho-
magenesis. Over time, infected macrophages migrate to future
secondary tumor sites where they likely establish a pre-metastatic
niche and set up a favorable environment for ARL metastatic cells.
Strikingly, we found that the viral effective population size (Ne)i n
the tumor clade for both patients expanded ,100 fold (from ,1t o
100) during the course of infection, while the viral population in
the non-tumor clade remained constant. Molecular clock analysis
revealed that the exponential increase of the Ne was not due to an
increased evolutionary or replication rate of HIV-1 in tissues with
different histopathology. The exponential increase in viral
population size, on the other hand, is consistent with an increase
number of macrophages within the tumor environment that are
susceptible to HIV-1 infection. Human tumors, including
lymphomas, secrete chemokines such as monocyte chemotactic
protein-1 (MCP-1), macrophage colony stimulating factor (M-
CSF), and VEGF, which are believed to be important for the
recruitment of macrophages into tumor sites [26,27]. Therefore,
tumor-derived chemokines could be attracting macrophages into
the tumor where they would be promoting tumor growth and
metastasis through TAM’s known pro-tumor properties as well as
becoming infected with HIV-1. Further support for this hypothesis
is that the majority of the gene flow in both patients was between
tumor and lymph nodes, while almost no gene flow was observed
between either tumor or lymph nodes and normal tissues. The
continuous recruitment-infection of new macrophages in tumor
tissues can explain the exponential growth of the tumor-associated
viral quasispecies that occurred at the onset of ARL and
progressed till patients’ death, and suggest that a similar HIV-1
population dynamic in TAMs may underlie ARL onset and
progression. One limitation of our study is that only two cases
could be included. We believe, however, that the highly significant
finding of HIV-1 compartmentalization in tumor and non-tumor
tissues in two patients with independent clinical histories and the
different numbers and sets of tissues analyzed should strengthen
the confidence in our results.
To date, the evolution of HIV infection in macrophages has
been primarily addressed in the context of the T-cell-free central
nervous system. These studies have identified macrophages as
long-lived reservoirs of HIV infection and replication and as sites
for increased viral recombination. TAMs are not targeted by
HAART. Most importantly, studies have shown that HIV infected
macrophages are not prone to cell lysis whereas T-cells are. These
facts make TAMs interesting in the context of how virus
populations might persist and migrate in the context of
macrophage-associated disease processes, such as lymphoma and
dementia. The evolution of HIV within TAMs likely represents an
entirely different epigenetic event than that found in T-cells and
deserves increased attention in future studies.
Materials and Methods
Biomaterial
Multi-site frozen autopsy specimens (Supplemental Table S1) of
lymphoid and non-lymphoid tissues were obtained through the
AIDS and Cancer Specimen Resource (ACSR) (http://acsr.ucsf.
edu) from two patients who died with ARL as previously described
[21]. Tissues were classified as tumor, non-tumor, or mixed tissues
by histological examination, and stained with antibodies to CD68
and HIV p24 as described below. Quantitative HIV genetic
studies qualified tissues studied as having .1 copy of HIV/2000
genomic equivalents for further genetic analyses. The ACSR is a
National Cancer Institute funded tissue banking program that
obtains tissues from patients after appropriate consent and the
application of a de-identification procedure before sending the
tissues out to ACSR-approved investigators. Clinical histories are
handled similarly in a de-identified manner. Patient two-letter
designations used throughout this study were generated randomly
as shorthand used by technicians who performed the studies so as
not to have any correlation to patient information. The ACSR is
recognized by the Office of Biorepositories and Biospecimen
Research at the National Institutes of Health as being HIPAA
compliant and in accordance with the ethical standards of the
Declaration of Helsinki. Additionally, all material was obtained
under approval from the UCSF committee on human research.
Subjects
Subject AM died without HAART or cancer chemotherapy.
Two months prior to death he presented with lymphadenopathy
and peripheral edema with a left axillary lymph node biopsy
showing follicular hyperplasia. The subject had a two week history
of weight loss and fever with a painful left axillary lymph node and
palpable nodes elsewhere. Autopsy findings were significant for
EBV negative disseminated large-cell lymphoma involving the
stomach, pancreas, spleen, left kidney, all sampled lymph nodes,
and portions of the diaphragm, and liver. There was no evidence
of tumors in the prostate, right kidney, or brain.
Patient IV died without HAART or cancer chemotherapy. Two
weeks prior to death the subject presented with ascites. One week
later the subject developed diffuse adenopathy and fevers. High-
grade lymphoma was diagnosed in the bone marrow 1 day prior to
death. Autopsy findings were significant for high-grade EBV
positive lymphoma involving spleen, intestines, kidney, dia-
phragm, all sampled lymph nodes, and portions of the stomach.
The brain showed multinucleated giant cells and perivascular
macrophage cuffing consistent with HIV associated encephalitis.
Histology
Frozen samples from multi-site autopsies were fixed in 10%
neutral buffered formalin and embedded in paraffin. The samples
were sectioned at 5um, stained with hematoxylin and eosin (H&E),
and examined by light microscopy as we previously described
16.
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non-tumor, tumor, or mixed tissues.
CD68 and p24 immunohistochemistry was performed using
fixed samples that were matched to the frozen tissues analyzed by
H&E. After deparaffinization, rehydration, washing, and heat-
induced epitope retrieval, the slides were treated with mouse anti-
HIV p24 (Dako, 1:10) in 1X wash buffer overnight at 4C. The
slides were then rinsed and treated with anti-mouse Envi-
sion+HRP, followed by DAB. Slides were then microwaved in
antigen retrieval solution to remove the remaining antibodies.
After cooling, monoclonal mouse anti-human CD68 clone PGM1
(DAKO, Denmark, 1:25) in 1X wash buffer was applied for 45
minutes (Dako) at room temperature. Slides were then treated with
anti-mouse Envision+AP for 45 minutes followed by Vector Red
alkaline phosphatase substrate (Vector Laboratories, Burlingame,
CA), counterstained with Mayer’s hematoxylin (1:2) and examined
by light microscopy.
Amplification, Cloning and Sequencing
Amplification, cloning, and sequencing of the envelope gp120
viral protein were analyzed using primers and conditions
previously described [21]. Briefly, genomic DNA was extracted
from 10–30 mg of the total frozen biopsy tissue from each tissue
listed in supplemental table S1 using the QIAmp DNA Mini Kit
from Qiagen according to the manufacture’s protocol. A 3.3 kb
HIV fragment, spanning the env to the 39LTR region was
amplified by PCR. PCR products were cloned into the pCR2.1-
TOPO vector. Clones containing the proper insert were identified
with PCR. Sequencing was preformed on approximately 20–40
clones derived from each biopsy tissue by MCLab (South San
Francisco). Putative recombinant sequences were excluded from
further analysis. The final data sets consisted of 197 sequences
from subject AM and 146 sequences from subject IV. Multiple-
sequence alignments were obtained by codon-alignment with the
CLUSTAL algorithm [28], and subsequent manual editing for
optimization. Putative recombinant sequences were detected by
using the PHI-test based algorithm as previously described
[29,30].
Phylogenetic Analysis of Non-Recombinant Data Sets
The best fitting nucleotide substitution model was tested with a
hierarchical likelihood ratio test, using a neighbor-joining (NJ) tree
with LogDet corrected distances [31]. Maximum likelihood (ML)
trees were inferred with the selected model and ML-estimated
substitution parameters. The heuristic search for the best tree was
performed using an NJ tree as a starting tree and the TBR branch-
swapping algorithm. Neighbor-Joining (NJ) trees were estimated
using pair-wise distances inferred by ML with the best fitting
nucleotide substitution model. Calculations were performed with
PHYML [32]. Statistical support for internal branches of each tree
was obtained by bootstrapping (1000 replicates for the NJ trees;
200 replicates for the ML trees). Each tree was rooted using ML by
selecting the rooted tree with the best likelihood under the
molecular clock constraint or by outgroup rooting using strains
from the other subject. The location of the root was confirmed by
inferring rooted Bayesian trees with a relaxed clock model. Since
sequences were all collected at the same time point (post mortem)w e
used a strong prior for the evolutionary rate using a previous
estimate of 1.2 10
22 nucleotide substitutions per site per year
based on several independent intra-patient data sets [19,33]. The
Bayesian calculation consisted of 100,000,000 generations Markov
Chains Monte Carlo (MCMC) with sampling every 10,000
th
generation using the BEAST software package version 1.4 [34].
Convergence of the MCMC was assessed by calculating the
effective sampling size (ESS) of the combined runs. All parameter
estimates showed significant ESS (.300). Bayesian trees were also
obtained with the program MrBayes v3.1.2, using the HKY+C
model running in parallel two MCMC for 10,000,000 generations
with sampling every 100
th generation [35]. Convergence was
assessed by comparing the average standard deviation of split
frequencies (p,0.0001). Statistical support for each clade in the
Bayesian trees was obtained by calculating clade-specific Bayesian
posterior probabilities with MrBayes. In each case, ML and
Bayesian methods inferred the same topology. For each dataset,
the maximum clade credibility tree, which is the tree with the
largest product of posterior clade probabilities, was selected from
the posterior tree distribution after 10% burn in using the program
TreeAnnotator version 1.4.8. Final trees were manipulated in
FigTree v.1.1.2 for display (http://evolve.zoo.ox.ac.uk/beast/).
Coalescent Models
By using coalescent theory, we can infer the demographic
history of a population from the genealogical relationships of
sampled individuals [36,37]. A genealogy reconstructed from
randomly sampled HIV sequences contains information about
population-level processes such as change in population size and
growth rate. Given a viral phylogeny P and a vector w representing
the parameters of a demographic model N(t), it is possible to
calculate the log of the conditional probability ln[w|P]. Bayesian
estimates of w can be found by MCMC sampling procedure. We
considered six demographic models for the each data set: constant
population size with strict or relaxed molecular clock, exponential
growth with strict or relaxed molecular clock, and Bayesian skyline
plot (BSP) with strict or relaxed molecular clock. Both parametric
(constant or exponential model) and non-parametric (BSP)
estimates of demographic history were performed with BEAST
version 1.8 by running one MCMC for 100,000,000 generations
with sampling every 10,000
th generation. Each aligned data set
was partitioned in 1
st+2
nd and 3
rd codon positions and the
parameters of the nucleotide substitution (HKY+C+I) and
demographic model were estimated independently for ach
partition. All parameter estimates showed significant ESS (.300).
While the constant and the exponential model are nested, the
BSP is a non-parametric model that cannot be compared with the
other two by comparing the mean log posterior probabilities.
However, model comparison in a Bayesian framework can be
achieved by calculating the Bayes Factor (BF), which is the ratio of
the marginal likelihoods with respect to the prior of the two models
being compared [38]. We calculated approximate marginal
likelihoods for each coalescent model via importance sampling
(1000 bootstraps) using the harmonic mean of the sampled
likelihoods with the posterior as the importance distribution [39].
The calculations were performed with Tracer 1.4 (http://evolve.
zoo.ox.ac.uk/beast/). Twice the difference in loge space of
marginal likelihood between any two models is the Bayes Factor,
2loge(BF). Evidence against the null model (i.e. the model with
lower marginal likelihood) is assessed in the following way:
2.[2loge(BF)] indicates no evidence against the null model;
10.[2loge(BF)].6 indicates positive to strong evidence against
the null model; [2loge(BF)].10 indicates very strong evidence
against the null model [38].
Gene Flow Tests and Migration Counts
The hypothesis of compartmentalization, i.e. the existence of
distinct HIV-1 sub-populations within different tissues, was tested
by the Slatkin and Maddison test [18] for gene flow using the
MacClade version 4 program [40]. A one-character data matrix
was obtained from the original data set by assigning to each taxon
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maximum clade credibility tree was obtained from the distribution
of phylogenetic trees (minus the burnin) from Bayesian analysis
and imported into MacClade. Then, the putative origin of each
ancestral sequence (i.e. internal node) in the tree was inferred with
the Fitch algorithm by finding the most parsimonious reconstruc-
tion (MPR) of the ancestral character. The final result was a tree
with colored branches, where each color represented the tissue of
origin of the internal node (ancestral sequence) or tip node (actual
sequence) subtending that branch. A change in color (i.e. in tissue
assignment) between two branches connected through a node
represented a migration event from one tissue to another that must
have occurred during the genealogical evolution of the sequences
under investigation. The tree-length, i.e. the total number of
observed migrations in the genealogy, computed by MacClade
was then compared to the tree-length distribution of 10,000 trees
obtained by random joining-splitting. Observed genealogies
significantly shorter than random trees indicated the presence of
subdivided populations. Specific migrations among different
compartments (states) were traced with the State changes and stasis
tool (MacClade), which counts the number of changes in a tree for
each pair-wise state as previously described [16]. When multiple
MPRs were present, the algorithm calculated the average
migration count over all possible MPRs for each pair. The
resulting pair-wise migration matrix was normalized to obtain the
percentage of observed migration to/from different tissues in the
tree.
Molecular Clock Analysis
Three different molecular clock models were tested: 1) a strict
molecular clock (SC), which assumes the same evolutionary rate
for all lineages, 2) a local molecular clock (LC), which assumes
different evolutionary rates for the clade containing HIV-1
sequences isolated from tumor tissues and the one including viral
strains isolated from normal tissues and, 3) no clock (NC), which
allows for a different evolutionary rate along each branch of the
tree. Calculations were performed with the BASEML program of
the PAML 4.0 package [41] using the tree topologies estimated
with BEAST and MrBayes. The clock hypothesis was investigated
at both synonymous and nonsynonymous sites by analyzing
separately synonymous 3




nd codon position (nonsyn cdp) for each alignment. Different
clock hypotheses were tested with the likelihood ratio test. Degrees
of freedom for the test between global and local clock models were
calculated by considering that for a binary tree, a local clock model
has n-1+r free parameters, where r is the number of unconstrained
relative evolutionary rates [41].
Prediction of HIV-1 Co-Receptor Usage
Net charge of V3 based on number and position of amino acid
residues [K+D]-[D+E] was calculated in HIVbase software [42],
and phenotype (co-receptor usage and cell tropism) was predicted
according to Briggs et al. algorithm (2000) [17]. The result was
confirmed by using the geno2pheno algorithm (http://www.
geno2pheno.org/).
Supporting Information
Table S1 Pathological characteristics of tissues from patient AM
and IV. a. Mixed tissues contained both tumor and non-tumor
cells within the tissue sample.
Found at: doi:10.1371/journal.pone.0008153.s001 (0.04 MB
DOC)
Table S2 Bayes Factors comparison of viral growth models in
tumor and normal tissues. 1. Null hypothesis: constant viral
population size. 2. Alternative hypotheses: exponential growth or
Bayesian Skyline Plot (BSP). 3. Bayes factor in loge units. 4.
Statistical significance was assessed according to the Bayes factors
significance tables in Kass and Raftery (1995).
Found at: doi:10.1371/journal.pone.0008153.s002 (0.03 MB
DOC)
Table S3 Molecular clock analysis of HIV-1 gp120 intra-host
quasispecies. 1. Three molecular clock models were evaluated: a
non-clock model (NC), assuming a separate rate for each branch in
the tree; a local clock model (LC), assuming two different
evolutionary rates for the tumor and non-tumor clade, respectively
(see Figure 2), and a strict clock model (SC) assuming one
evolutionary rate for the entire tree. 2. loge(Lk) is the natural
logarithm of the likelihood estimated for each model using the
trees in Figure 2. 3. Likelihood ratio test (LRT) performed to
compare the general (left) vs. the null (right) hypothesis. For each
comparison, the best fitting model is the one highlighted in bold.
Found at: doi:10.1371/journal.pone.0008153.s003 (0.04 MB
DOC)
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